HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section. A comparative trial.

Abstract
A prospective, double-blind study was performed to evaluate the comparative efficacy of single- and multiple-dose antimicrobial prophylaxis for preventing infection in high-risk patients undergoing cesarean section. One hundred fifty-eight patients were randomly assigned to receive either a single perioperative dose of mezlocillin, three doses of mezlocillin or three doses of cefoxitin. The incidence of endometritis was 5.9%, 4.0% and 4.0%, respectively. The incidence of febrile morbidity was 5.9%, 2.0% and 6.1%, respectively. These differences are not statistically significant. The single perioperative dose of mezlocillin was as effective as the three-dose regimen of either mezlocillin or cefoxitin.
AuthorsD H Saltzman, L J Eron, R E Tuomala, L J Protomastro, J G Sites
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 31 Issue 8 Pg. 709-12 (Aug 1986) ISSN: 0024-7758 [Print] United States
PMID3772891 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cefoxitin
  • Mezlocillin
Topics
  • Adult
  • Bacterial Infections (prevention & control)
  • Cefoxitin (administration & dosage, therapeutic use)
  • Cesarean Section
  • Double-Blind Method
  • Endometritis (etiology, microbiology)
  • Female
  • Humans
  • Mezlocillin (administration & dosage, therapeutic use)
  • Postoperative Complications
  • Pregnancy
  • Premedication
  • Prospective Studies
  • Random Allocation
  • Urinary Tract Infections (etiology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: